Natural resistance to cancer: A window of hope

Int J Cancer. 2024 Apr 1;154(7):1131-1142. doi: 10.1002/ijc.34766. Epub 2023 Oct 20.

Abstract

As healthcare systems are improving and thereby the life expectancy of human populations is increasing, cancer is representing itself as the second leading cause of death. Although cancer biologists have put enormous effort on cancer research so far, we still have a long way to go before being able to treat cancers efficiently. One interesting approach in cancer biology is to learn from natural resistance and/or predisposition to cancer. Cancer-resistant species and tissues are thought-provoking models whose study shed light on the inherent cancer resistance mechanisms that arose during the course of evolution. On the other hand, there are some syndromes and factors that increase the risk of cancer development, and revealing their underlying mechanisms will increase our knowledge about the process of cancer formation. Here, we review natural resistance and predisposition to cancer and the known mechanisms at play. Further insights from these natural phenomena will help design future cancer research and could ultimately lead to the development of novel cancer therapeutic strategies.

Keywords: carcinogenesis; lifespan; malignancy; resistance to cancer; tumor.

Publication types

  • Review

MeSH terms

  • Disease Susceptibility
  • Genotype
  • Humans
  • Immunity, Innate
  • Neoplasms* / drug therapy